New Trials, New Targets: New Hope for Alzheimer’s
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and new therapeutic targets fueling cautious hope.
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and new therapeutic targets fueling cautious hope.
A patient and clinicians provide essential perspectives on multiple sclerosis (MS) care. Join us for an in-depth discussion on disability progression in MS.
Veterans Affairs data-based study finds that changing from MDI to DPI is linked to greater healthcare use, though the veteran population is often sicker than…
Direct challenges with oral amoxicillin are as safe as skin testing for evaluating penicillin allergy in low-risk pregnant women, researchers report.
A survey of caregivers of children with moderate-to-severe perennial allergic rhinitis reveals a high burden of disease.
Indolent Systemic Mastocytosis: Building Bridges of Support and Understanding for Patients and Caregivers
A novel MRI-based ‘aging’ clock may offer a simple way to identify patients whose biological age is outpacing their chronological age, allowing for early intervention.
Younger doctors are demanding balance — will the system finally listen?
Does being board-certified make a young oncologist practice-ready? Dr Bishal Gyawali discusses the disconnect between oncology board exams, guidelines, and real-world practice.
Full-body immersion in cold water remains the gold standard for exertional heat stroke, crucially reducing organ damage and mortality rates.
Contact allergies linked to wearables like smartwatches and earbuds are rising, with nickel and acrylates among the top allergens, a French dermatologist reports.